Dr. Alan R. Wladis, MD

Dr. Wladis practices at Adventhealth Diabetes Institute Orlando - HOPD in Orlando, Florida.

Dr. Wladis' NPI, 1568578631, was assigned on August 22, 2006. Dr. Wladis graduated from SUNY Upstate Medical University in 1992. Dr. Wladis holds Florida license ME80259.

Dr. Wladis' primary practice is Adventhealth Diabetes Institute Orlando - HOPD, at 2415 N Orange Ave, Orlando, FL 32804.

Dr. Wladis' primary practice is Adventhealth Diabetes Institute Orlando - HOPD in Orlando, Florida. Dr. Wladis is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Wladis to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Wladis' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wladis practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Wladis' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Wladis is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Wladis' licenses on file in 4 states: Florida, Ohio, New Jersey and Pennsylvania.

Dmand AI lists amputation, aortic atherosclerois, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Wladis treats.

CMS data shows 1,600 Medicare services from Dr. Wladis across 21 procedure codes in 2024, for 905 Medicare patients. Medicare paid $119,857 for them.

CMS counts 905 Medicare patients who saw Dr. Wladis in 2024. The largest group is 65 to 74, with 352 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wladis' median patient age at 70, with 45% women.

In 2024, Dr. Wladis wrote 260 Medicare Part D claims for 110 patients. 90% of them were for generic drugs. CMS names the drug for 241 of them, across 4 drugs with 11 or more claims each, at $14,914 in total drug cost. In 2023, CMS named 281 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Wladis for performance year 2024, reported as part of a group. Dr. Wladis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Wladis in 2021. The most frequent topics are Blood Flow Velocity and Postoperative Period. Dr. Wladis' most frequent co-authors are Harvey Edward Garrett, MD, Gregory C. Kasper, MD and Joseph V. Lombardi, MD.

CMS Open Payments shows 405 general payments to Dr. Wladis from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Endologix, Inc. paid the most, $4,697.

Dr. Wladis graduated from SUNY Upstate Medical University in 1992.

Dr. Wladis is in network with 20 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.